Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 15 (4) , 882-894
Abstract
Acute myeloid leukemia (AML) with mutated nucleophosmin (NPM1) has been defined as a distinct leukemia entity in the 2016 updated WHO classification of myeloid neoplasm. Our previous report showed that autophagic activity was elevated in NPM1-mutated AML, but the underlying molecular mechanisms remain elusive. Mount of study provides evidence that glycometabolic enzymes are implicated in the autophagic process. Pyruvate kinase isoenzyme M2 (PKM2), a key glycolytic enzyme, has been recently reported as a tumor supporter in leukemia. However, little is known about the roles of PKM2 in autophagic activity in NPM1-mutated AML. In this study, PKM2 highly expressed in NPM1-mutated AML, and partially, high levels of PKM2 were upregulated by PTBP1. Further experiments demonstrated that PKM2 mediated autophagic activation and increased the phosphorylation of key autophagy protein Beclin-1. Importantly, functional experiments demonstrated that PKM2 contributed to cell survival via autophagic activation. Ultimately, high PKM2 expression was associated with short overall and event-free survival time in NPM1-mutated AML patients. Our findings indicate for the first time that glycolytic enzyme PKM2 mediates autophagic activation and further contributes to cell survival in NPM1-mutated AML, suggesting that PKM2 may serve as a promising target for treatment of NPM1-mutated AML.Keywords
This publication has 44 references indexed in Scilit:
- Biological and clinical consequences of NPM1 mutations in AMLLeukemia, 2017
- ‘Acute myeloid leukemia: a comprehensive review and 2016 update’Blood Cancer Journal, 2016
- Autophagy in acute leukemias: A double-edged sword with important therapeutic implicationsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015
- Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogeneticsLeukemia Research, 2014
- Involvement of polypyrimidine tract-binding protein (PTBP1) in maintaining breast cancer cell growth and malignant propertiesOncogenesis, 2014
- Pyruvate Kinase M2 Regulates Gene Transcription by Acting as a Protein KinaseMolecular Cell, 2012
- Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regressionJournal of Experimental Medicine, 2012
- Detection of exon 12 type A mutation of NPM1 gene in IMS-M2 cell lineLeukemia Research, 2010
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancerNature, 2009
- Genes of glycolysis are ubiquitously overexpressed in 24 cancer classesGenomics, 2004